Hlx10 serplulimab
Web28 mag 2024 · Efficacy and safety of HLX10, a novel anti-PD-1 antibody, in patients with previously treated unresectable or metastatic microsatellite instability-high or mismatch repair-deficient solid tumors: A single-arm, multicenter, phase 2 study. Journal of Clinical Oncology Journal of Clinical Oncology > List of Issues > Volume 39, Issue 15_suppl > Web17 set 2024 · SHANGHAI, Sept. 17, 2024 /PRNewswire/ -- Shanghai Henlius Biotech Inc. (2696.HK) announced that the New Drug Application (NDA) of Serplulimab Injection (HLX10), a novel anti-PD-1 monoclonal antibody (mAb) independently developed by the company, in combination with carboplatin and albumin-bound paclitaxel for first-line …
Hlx10 serplulimab
Did you know?
Web27 set 2024 · Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 … Web19 ott 2024 · Serplulimab (HLX10) is a novel humanised monoclonal anti-PD-1 antibody. In a phase I study involving patients with previously treated advanced or metastatic solid …
Web1 nov 2024 · Serplulimab (HLX10) is a novel humanised monoclonal anti-PD-1 antibody. In a phase I study involving patients with previously treated advanced or metastatic solid … Web23 apr 2024 · SHANGHAI, April 23, 2024 /PRNewswire/ — Shanghai Henlius Biotech, Inc. (2696.HK) announced that the New Drug Application (NDA) of serplulimab injection (HLX10), a novel anti-PD-1 monoclonal antibody (mAb), for the treatment of unresectable or metastatic microsatellite instability-high (MSI-H) solid tumors that fail to respond to the …
Web27 set 2024 · Among patients with previously untreated extensive-stage SCLC, serplulimab plus chemotherapy significantly improved overall survival compared with chemotherapy alone, supporting the use of serplulimab plus chemotherapy as the first-line treatment for this patient population. Trial registration: Web7 apr 2024 · The FDA has granted orphan drug designation to serplulimab (HLX10) for the treatment of patients with small cell lung cancer (SCLC), according to a press release …
Web1 ago 2024 · HLX10 plus albumin-bound paclitaxel. A phase II clinical study (NCT04150575) investigated HLX10 (a new anti-PD-1 antibody) combined with albumin and paclitaxel as second-line therapy for...
Web14 set 2024 · A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With Bevacizumab（HLX04) and Chemotherapy (XELOX) in Patients With … show cdp neighborWebSerplulimab 汉斯状®) is an ... HLX10 Class Antineoplastics, antivirals, immunotherapies, monoclonal antibodies Mechanism of action Inhibits PD-1-related immunosuppression, thereby stimulating an immune response against tumours Route of … show celebrating americaWebHansizhuang (serplulimab) Evaluate the Efficacy, Safety and Tolerability of HLX26 and HLX10 in Patients With Metastatic Colorectal Carcinoma That Have Received 3 Prior Lines of Therapy (clinicaltrials.gov) P2, N=49, Not yet recruiting, Shanghai Henlius Biotech. 5 months ago. New P2 trial • Combination therapy • Metastases. show cell links in excelWeb7 set 2024 · Questo è uno studio clinico multicentrico di fase III a due bracci, randomizzato, in doppio cieco per valutare l'efficacia clinica di Serplulimab (HLX10) in com.... Registro delle prove cliniche. ICH GCP. show cell phone last locationWeb1 set 2024 · Serplulimab (formerly HLX10) is a fully humanized IgG 4 monoclonal antibody against the PD-1 receptor. In a phase 1 trial, up to 10 mg/kg of serplulimab was well tolerated and demonstrated similar pharmacokinetic characteristics to pembrolizumab and nivolumab. 13 Serplulimab showed antitumor activity and a manageable adverse event ... show celebrareWeb17 set 2024 · SHANGHAI, Sept. 17, 2024 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the New Drug Application (NDA) of Serplulimab Injection … show celebrationWeb7 lug 2024 · Serplulimab (汉斯状 ®) is an intravenously administered anti-PD-1 antibody being developed by Shanghai Henlius Biotech, Inc. for the treatment of solid tumours. … show celebrity